[HTML][HTML] Prediction of cytomegalovirus reactivation by recipient cytomegalovirus-IgG titer before allogeneic hematopoietic stem cell transplantation
S Kawamura, H Nakasone, J Takeshita… - … and Cellular Therapy, 2021 - Elsevier
Recipient cytomegalovirus (CMV) seropositivity is known to be a risk factor for CMV
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
[HTML][HTML] Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation
S Kawamura, H Nakasone, J Takeshita… - … and Cellular Therapy …, 2021 - tctjournal.org
Recipient cytomegalovirus (CMV) seropositivity is known to be a risk factor for CMV
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation.
S Kawamura, H Nakasone, J Takeshita… - … and Cellular Therapy, 2021 - europepmc.org
Recipient cytomegalovirus (CMV) seropositivity is known to be a risk factor for CMV
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
[引用][C] Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation
S Kawamura, H Nakasone, J Takeshita… - … and Cellular Therapy, 2021 - cir.nii.ac.jp
Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before
Allogeneic Hematopoietic Stem Cell Transplantation | CiNii Research CiNii 国立情報学 …
Allogeneic Hematopoietic Stem Cell Transplantation | CiNii Research CiNii 国立情報学 …
[HTML][HTML] Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation
S Kawamura, H Nakasone, J Takeshita… - … and Cellular Therapy …, 2021 - astctjournal.org
Recipient cytomegalovirus (CMV) seropositivity is known to be a risk factor for CMV
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation
S Kawamura, H Nakasone… - Transplantation …, 2021 - pubmed.ncbi.nlm.nih.gov
Recipient cytomegalovirus (CMV) seropositivity is known to be a risk factor for CMV
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
[HTML][HTML] Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation
S Kawamura, H Nakasone, J Takeshita… - … and Cellular Therapy …, 2021 - astctjournal.org
Recipient cytomegalovirus (CMV) seropositivity is known to be a risk factor for CMV
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …